Blog
RSS FeedPosted by Michael Wonder on 10 Dec 2017
Rare cancer treatment a success for Jie Eccles
9 December 2017 - Six months ago Jie wrote an open letter to the readers of news.com.au asking them to help ...
Posted by Michael Wonder on 09 Dec 2017
NICE nods for AbbVie in hepatitis C and Novartis in lung cancer
8 December 2017 - NICE has published new draft guidance for Novartis' Zykadia and AbbVie's Maviret. ...
Posted by Michael Wonder on 08 Dec 2017
New deal will give people with kidney cancer another treatment option
8 December 2017 - People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said ...
Posted by Michael Wonder on 08 Dec 2017
Decision to fund methylnaltrexone in palliative care
8 December 2017 - PHARMAC is pleased to announce the approval of an agreement with Link Pharmaceuticals Limited for the ...
Posted by Michael Wonder on 08 Dec 2017
Consumer outcome statement for the post-market review of PAH medicines
8 December 2017 - A consumer session was held with patients with PAH and their carers during the PHAA Members Carers ...
Posted by Michael Wonder on 08 Dec 2017
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis - stakeholder forum outcome
8 December 2017 - A stakeholder forum was held for the post-market review of the use of biologics in the ...
Posted by Michael Wonder on 07 Dec 2017
Roche’s Tecentriq available via CDF
7 December 2017 - Roche’s Tecentriq will be available on the NHS in England via the Cancer Drugs Fund for ...
Posted by Michael Wonder on 07 Dec 2017
Consumers’ voice drives digital health
7 December 2017 - Health consumers are central to the design and delivery of a digital transformed health sector and ...
Posted by Michael Wonder on 07 Dec 2017
NICE launches PRIMA to health-check economic models
7 December 2017 - NICE Scientific Advice offers a new service for healthcare product developers to check the quality of their ...
Posted by Michael Wonder on 07 Dec 2017
The drugs we couldn't get enough of: more than 200 cases of shortages over six years
7 December 2017 - Drugs to treat depression, Parkinson's disease, head lice, scabies and migraines ran out 11 times over ...
Posted by Michael Wonder on 07 Dec 2017
ALK secures pricing and reimbursement for Acarizax in France
30 November 2017 - ALK today announced that it has reached a satisfactory agreement with health authorities in France for ...
Posted by Michael Wonder on 07 Dec 2017
PHARMAC commits to equity target by 2025
7 December 2017 - Achieving equity in medicines access is one of the bold goals PHARMAC has set itself to ...
Posted by Michael Wonder on 06 Dec 2017
Growth of private care in public hospitals raises equity questions
6 December 2017 - A new report showing that public patients wait twice as long for elective surgery as private ...
Posted by Michael Wonder on 06 Dec 2017
International harmonisation of ingredient names – update on PBS changes
6 December 2017 - While some of the changes to active ingredient names have already appeared in the PBS Schedule, ...
Posted by Michael Wonder on 06 Dec 2017
Direct supply risks
6 December 2017 - The proliferation of exclusive direct supply arrangements has the potential to put at risk the core ...